Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Form 8.3 - Clarity Commerce Solutions plc

20 Oct 2011 17:19

RNS Number : 5795Q
Ken Smith
20 October 2011
Β 

ο»Ώ

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Identity of the person whose positions/dealings are being disclosed:

Mr Kenneth Ronald Smith

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

-

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Clarity Commerce Solutions PLC, (the "Company")

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

-

(e) Date position held/dealing undertaken:

19/10/11

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Ordinary shares of 25 pence each in the Company

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

445,000

1.07

0

0

(2) Derivatives (other than options):

0

0

0

0

(3) Options and agreements to purchase/sell:

0

0

0

0

Β 

TOTAL:

445,000

1.07

0

0

Β 

Β 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Β 

Class of relevant security in relation to which subscription right exists:

Options over ordinary shares of 25 pence each in the Company

Details, including nature of the rights concerned and relevant percentages:

Details

Grant date

No. of shares

Class

Exercise period

Exercise price

From

To

2010 EBT*

24 Apr 10

865,255

Ordinary

30 Sept 11

30 Sept 12

Nil

2010 EMI**

24 Apr 10

299,999

Ordinary

30 Sept 11

30 Sept 12

Nil

* Shares arising from 2010 EBT options may not be sold until 30/9/12 unless there is a change of control of the Company

** 2010 EMI options vest only upon change of control of the Company

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

Β 

Nature of dealing

Β 

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

Β 

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

Β 

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

Β 

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

20/10/11

Contact name:

Sara Anscombe - Thesis Asset Management

Telephone number:

01483 304183

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETMMBFTMBBTBRB
Date   Source Headline
14th Dec 20217:00 amRNSNew Customer National Nuclear Laboratory
18th Nov 20217:00 amRNSAppointment of Danone S.A. CISO to Advisory Board
11th Nov 20218:00 amRNSLong Term Incentive Plan Approval and Awards
9th Nov 20217:00 amRNSDarkbeam Collaboration
2nd Nov 20217:00 amRNSInvestor Presentation Webinar
26th Oct 20214:41 pmRNSSecond Price Monitoring Extn
26th Oct 20214:35 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSNotice of Investor Presentation
27th Sep 20217:00 amRNSHalf-year Report
15th Sep 20217:00 amRNSAppointment of URENCO CISO to Advisory Board
31st Aug 202112:00 pmRNSTotal Voting Rights
18th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
16th Aug 20217:00 amRNSHolding(s) in Company
10th Aug 20213:00 pmRNSGrant of Options to Director and Others
9th Aug 20217:00 amRNSAcquisition of Stega. Total Voting Rights
4th Aug 20215:23 pmRNSHolding(s) in Company
4th Aug 20213:33 pmRNSHolding(s) in Company
4th Aug 20218:02 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSTotal Voting Rights
28th Jul 202111:05 amRNSSecond Price Monitoring Extn
28th Jul 202111:00 amRNSPrice Monitoring Extension
28th Jul 20217:00 amRNS£5m Fundraising, Acquisition, Total Voting Rights
29th Jun 20217:00 amRNSSpotlight Sports Group implements Rizikon Pro
28th May 20214:41 pmRNSSecond Price Monitoring Extn
28th May 20214:35 pmRNSPrice Monitoring Extension
28th May 202112:00 pmRNSTotal Voting Rights
26th May 20215:33 pmRNSCorrection - Acquisition of VCL. TVR
26th May 20217:00 amRNSAcquisition of Verifiable Credentials Limited. TVR
25th May 20213:26 pmRNSAGM Result. Board Changes. Share sub-division. TVR
20th May 20217:00 amRNSNotice of Investor Presentation
18th May 20217:00 amRNSMOU with Al-Rawahy Holdings of Sultanate of Oman
10th May 20217:00 amRNSHolding(s) in Company
27th Apr 20217:00 amRNS2020 Annual Results; AGM Notice; Board Changes
16th Mar 20217:00 amRNSCrossword Consulting Helps Vital Signs Solutions
4th Mar 20214:37 pmRNSIASME to deliver CFF Certification using Rizikon
4th Mar 20217:00 amRNSIASME to deliver CFF Certification using Rizikon
1st Mar 202112:26 pmRNSCrossword CEO Tom Ilube CBE appointed Chair of RFU
23rd Feb 20217:00 amRNSUniversity of Glasgow Collaboration
15th Feb 20216:01 pmRNSHolding(s) in Company
12th Feb 20214:45 pmRNSHolding(s) in Company
10th Feb 20211:56 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNS£1.6m Fundraising
27th Jan 20217:00 amRNSRizikon Assurance Promotion to CIISec Members
19th Jan 20217:00 amRNSTrading Update
6th Jan 20215:28 pmRNSReplacement - Webinar Panel Discussion
6th Jan 20217:00 amRNSWebinar Panel Discussion on Cyber Skills Shortage
15th Dec 20207:00 amRNSCrossword wins Innovate UK Grant
11th Dec 20207:00 amRNSSupporting Sultan Qaboos University competition
25th Nov 20207:00 amRNSRizikon Assurance selected by IASME Consortium
10th Nov 202011:07 amRNSCrossword to work on Covid-19 Certificates Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.